The 10,000 sq. ft. facility brings assay development, instrument engineering and artificial intelligence teams together to support the development of point-of-care diagnostic platforms.
Diagnostics startup Sciverse Solutions has opened a new headquarters and research centre in Pune, consolidating its assay-development, instrument-engineering and artificial-intelligence capabilities within one facility.
The 10,000 sq. ft. centre includes three connected laboratories focused on biological assays, diagnostic instrumentation and artificial intelligence, according to a company statement.
Sciverse said the facility would support the end-to-end development of diagnostic systems, covering assay chemistry, optical detection, microfluidics, biosensors, embedded systems and software used to interpret test results.
The company is developing platforms for point-of-care haematology and molecular diagnostics. These systems are intended to enable diagnostic testing closer to patients, including in clinics and healthcare settings that may not have access to central laboratory infrastructure.
According to Sciverse, its artificial-intelligence laboratory is developing SciVision, a software platform designed to interpret diagnostic and medical-imaging data and support its instruments.
Rahul Singh, Founder and Managing Director of Sciverse, said the centre was intended to strengthen the company’s ability to design diagnostic technologies within India.
“When the biology, the hardware and the software sit in the same building, we can create tests that a small clinic can actually use, without the equipment a large hospital takes for granted,” Singh said.
Jatin Jagani, Co-Founder of Sciverse, said bringing the different technical teams together could shorten the process of integrating assays with working diagnostic instruments.
The company said several of its platforms are undergoing clinical evaluation. Details of the studies and the regulatory status of the products were not disclosed in the announcement.
Sciverse was founded in 2022 and works on point-of-care diagnostics, medical imaging software and molecular-testing platforms. The company also provides product-development services to diagnostics companies that may market the resulting technologies under their own brands.
The Pune centre adds to domestic research and development capacity in a medical-device market that remains substantially dependent on imported technologies.
